IVF News and Research

RSS

StemCell Holding leads CHF 20 million investment in Pantec Biosolutions

Pantec Biosolutions AG, a privately-owned company developing innovative technologies for transdermal drug delivery, today announced the closing of a CHF 20 million investment achieved by two financing rounds. The StemCell Holding AG, an Austrian investment company in the life sciences sector, acted as lead investor.

20 Jul 2010

Univfy, Stanford scientists develop first validated prognostic test for predicting IVF live birth outcomes

Univfy, a pioneer in the development of personalized in vitro fertilization (IVF) prognostic tools, announced today the publication of new research findings in the journal Proceedings of the National Academy of Sciences (PNAS) by its founding scientific team and clinical collaborators from Stanford University.

20 Jul 2010

Funding ART in Québec is highly justified and ethical use of public funds, says IAAC

Following the announcement on July 13 by Québec's Minister of Health and Social Services, Dr. Yves Bolduc, that assisted reproduction treatments (ART) will be covered by the public health system of Québec as of August 5, 2010, many comments have been made about how this new policy will stress the public health system, and neonatology units in particular.

16 Jul 2010

EU requirement for HIV, hepatitis screening of ART couples at each donation unnecessary, distressing

European legislation that requires all couples undergoing assisted reproduction treatment (ART) to be screened for HIV and hepatitis at the time of every sperm or egg donation is unnecessary, expensive, and potentially distressing for patients, the 26th annual meeting of the European Society of Human Reproduction and Embryology heard Monday.

2 Jul 2010

Anti-aging supplement: A fountain of hope for would-be mothers

According to the American Pregnancy Association, six million women a year deal with infertility. Now, a Tel Aviv University study is giving new hope to women who want to conceive ― in the form of a pill they can find on their drugstore shelves right now.

2 Jul 2010

Babies born after IVM fertility treatment more likely to be born larger than normal

A review of studies of babies born after in vitro maturation (IVM) fertility treatment has suggested that they are more likely to be born larger than normal and to have more difficult births requiring more obstetric interventions such as caesareans.

1 Jul 2010

Follicle aspiration needle Swemed Sense gives less pain, bleeding compared with conventional needle

“The follicle aspiration needle Swemed Sense™ makes it possible to work in a new way, which is more favourable for patients, and at the same time it meets all the other quality requirements for a follicle aspiration needle”

1 Jul 2010

Rubicon Genomics' PicoPlex linear WGA technology proves effective in clinical study

Rubicon Genomics today announced that its PicoPlex linear whole genome amplification technology was proven to be effective in an independent clinical study organized by the European Society for Human Reproduction and Embryology. At a press conference during its 26th Annual Meeting in Rome, ESHRE reported the success of its "groundbreaking proof of principle study" showing that a new approach incorporating PicoPlex could more accurately detect and characterize chromosomal abnormalities in human eggs.

1 Jul 2010

Advanced 3D/4D ultrasound to guide embryo transfer during IVF reduces risk of ectopic pregnancy

Using advanced 3D/4D ultrasound to guide embryo transfer during in vitro fertilization (IVF) significantly reduces a woman's risk of ectopic pregnancy and its associated complications, Robert Gergely, M.D., medical director, 3D Sonography Center of Beverly Hills, reported today.

30 Jun 2010

ESHRE's EIM: Europe leads in Assisted Reproduction Technology

Europe leads the world in Assisted Reproduction Technology (ART) with most cycles initiated in the region, the 26th Annual Meeting of the European Society of Human Reproduction and Embryology heard today (Wednesday 30 June).

30 Jun 2010

Molecular Biometrics' ViaMetrics-E procedure accurately predicts implantation rates in SET IVF cycles

Researchers from Molecular Biometrics, Inc. presented new data this week demonstrating that the company's ViaMetrics-E procedure more accurately predicts implantation rates in single embryo transfer (SET) cycles for patients undergoing infertility treatment. ViaMetrics-E is a rapid, non-invasive procedure used to enhance in vitro fertilization (IVF) outcomes by identifying viable embryos having the greatest reproductive potential.

30 Jun 2010

Genetic variation makes women sub-fertile, less likely to respond to ovarian stimulating hormones

Researchers have discovered that some women carry a genetic variation that makes them sub-fertile and less likely to respond to ovarian stimulating hormones during fertility treatment. The discovery opens the way to identifying these women and devising personalised fertility treatments that could bypass the problem caused by the genetic abnormality.

30 Jun 2010

Repeated viral screening for ART patients unnecessary with each donation

30 Jun 2010

Ovarian transplant procedure increases lifespan, restores fertility in aging mice

Scientists have discovered that when they transplant ovaries from young mice into aging female mice, not only does the procedure make the mice fertile again, but also it rejuvenates their behaviour and increases their lifespan. The question now is: could ovarian transplants in women have the same effect?

29 Jun 2010

Genetic variation can impact women's response to ovarian stimulating hormones

29 Jun 2010

Telomere length could prove a quality marker for embryonic development

Scientists from the University of Warwick and University Hospitals Coventry and Warwickshire NHS Trust, are the first to directly measure a specific region of DNA in human embryos. The length of this region could be a quality marker for embryonic development.

29 Jun 2010

Scientists use PGS method to analyse chromosomal status of eggs

The efficacy of preimplantation genetic screening has been one of the most hotly disputed subjects in assisted reproduction over the past few years. The European Society of Human Reproduction and Embryology PGS Task Force has now shown, in its groundbreaking proof of principle study, that screening of polar bodies (small cells that are the by-product of egg development), is a reliable method to analyse the chromosomal status of an egg.

28 Jun 2010

Overweight women undertaking ART at increased risk of miscarriage

Being overweight leads to a greater risk of miscarriage for patients undergoing assisted reproductive technology (ART), the 26th annual conference of the European Society of Human Reproduction and Embryology heard today (Monday). Dr. Vivian Rittenberg, a Clinical Fellow in the Assisted Conception Unit, Guy's and St. Thomas' Hospital NHS Foundation Trust, London, UK, said that her research provided additional evidence to show that increased body mass index (BMI) was independently associated with a higher miscarriage rate after IVF or ICSI treatment.

28 Jun 2010

Better test to predict menopause on the horizon

With the rise of many women delaying when they have a baby until they are older researchers are developing a test that can now tell a woman in her twenties how long she has left to start a family.

28 Jun 2010

German IVF Register reports one-millionth treatment cycle in reproductive medicine

Dr. Klaus Buhler, President of the German IVF Register, has reported the one-millionth treatment cycle in reproductive medicine recorded by the IVF Register in Germany this year. Presently, ninety per cent of all centers for in-vitro fertilization (IVF) in Germany collect data from reproductive treatments using RecDate Advance by Merck Serono - a database system developed by the IT consulting firm CRITEX, and marketed under the name MedITEX IVF.

23 Jun 2010

IVF News and Research

StemCell Holding leads CHF 20 million investment in Pantec Biosolutions

Univfy, Stanford scientists develop first validated prognostic test for predicting IVF live birth outcomes

Funding ART in Québec is highly justified and ethical use of public funds, says IAAC

EU requirement for HIV, hepatitis screening of ART couples at each donation unnecessary, distressing

Anti-aging supplement: A fountain of hope for would-be mothers

Babies born after IVM fertility treatment more likely to be born larger than normal

Follicle aspiration needle Swemed Sense gives less pain, bleeding compared with conventional needle

Rubicon Genomics' PicoPlex linear WGA technology proves effective in clinical study

Advanced 3D/4D ultrasound to guide embryo transfer during IVF reduces risk of ectopic pregnancy

ESHRE's EIM: Europe leads in Assisted Reproduction Technology

Molecular Biometrics' ViaMetrics-E procedure accurately predicts implantation rates in SET IVF cycles

Genetic variation makes women sub-fertile, less likely to respond to ovarian stimulating hormones

Repeated viral screening for ART patients unnecessary with each donation

Ovarian transplant procedure increases lifespan, restores fertility in aging mice

Genetic variation can impact women's response to ovarian stimulating hormones

Telomere length could prove a quality marker for embryonic development

Scientists use PGS method to analyse chromosomal status of eggs

Overweight women undertaking ART at increased risk of miscarriage

Better test to predict menopause on the horizon

German IVF Register reports one-millionth treatment cycle in reproductive medicine

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News